Education
About Us
Working with TipRanks
Follow Us
Top UK Pharma & Biotech Shares
Compare up to 10 stocks
Comparison Results
Name | Price | Volume | Analyst Price Target | Analyst Consensus | Smart Score | Market Cap | P/E Ratio | Dividend Yield | Sector | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 10180.00p | 1.52M | xxxxxxxxxxxxx | 10 Buy 4 Hold 0 Sell Moderate Buy | £159.28B | 26.05 | 2.40% | Healthcare | |||
 | 1358.00p | 8.41M | xxxxxxxxxxxxx | 2 Buy 7 Hold 4 Sell Hold | £56.57B | 18.13 | 4.43% | Healthcare | |||
 | 209.50p | 79.97K | xxxxxxxxxxxxx | 1 Buy 0 Hold 0 Sell Moderate Buy | £1.84B | 62.94 | ― | Healthcare | |||
 | 1947.00p | 833.60K | xxxxxxxxxxxxx | 5 Buy 1 Hold 0 Sell Strong Buy | £4.31B | 15.79 | 3.09% | Healthcare | |||
 | $3866.00 | 192.11K | xxxxxxxxxxxxx | ― | $4.40B | ― | ― | ― |
Performance Comparison
GB:AZN
AstraZeneca
10,180.00
-1,816.41
-15.14%
GB:GSK
GlaxoSmithKline
1,358.00
-381.01
-21.91%
GB:HIK
Hikma Pharmaceuticals
1,947.00
4.06
0.21%
GB:HCM
HUTCHMED (China)
209.50
-134.50
-39.10%
GB:DPH
―
―
―
―
Pharma & Biotech Latest News
Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Pharma & Biotech Stocks
Most Recent Earnings of Pharma & Biotech Stocks
AstraZeneca
Apr 29, 2025
Mar 01, 2025
198
GlaxoSmithKline
Apr 30, 2025
Mar 01, 2025
43.4
HUTCHMED (China)
Mar 19, 2025
Dec 01, 2024
0.292
Hikma Pharmaceuticals
Feb 26, 2025
Dec 01, 2024
127
―
―
―
―
Pharma & Biotech - FAQ
Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
Hikma Pharmaceuticals - Strong Buy, based on 6 analyst ratings, 5 Buy, 1 Hold, and 0 Sell.
Are Pharma & Biotech stocks overpriced?
AstraZeneca's stock price is currently 10,180.00p, and its average 12-month price target is 13,340.17p.
GlaxoSmithKline's stock price is currently 1,358.00p, and its average 12-month price target is 1,404.46p.
HUTCHMED (China) 's stock price is currently 209.50p, and its average 12-month price target is 331.29p.
Hikma Pharmaceuticals's stock price is currently 1,947.00p, and its average 12-month price target is 2,427.00p.
's stock price is currently 3,866.00, and its average 12-month price target is N/A.
Which Pharma & Biotech stocks pay dividends?
AstraZeneca does not currently pay dividends.
GlaxoSmithKline currently pays a dividend of 16.00p which represents an annual dividend yield of 4.43%. GlaxoSmithKline's next Ex-dividend date is May 15, 2025 and its next payout date is July 10, 2025.
HUTCHMED (China) does not currently pay dividends.
Hikma Pharmaceuticals does not currently pay dividends.
does not currently pay dividends.